Clinical Trial: Safety and Efficacy Study of Ferric Maltol To Treat Iron Deficiency Anaemia in Chinese Patients With Inflammatory Bowel Disease

U.S., Aug. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07739368) titled 'Safety and Efficacy Study of Ferric Maltol To Treat Iron Deficiency Anaemia in Chinese Patients With Inflammatory Bowel Disease' on July 22.

Brief Summary: The purpose of this study is to determine whether Ferric Maltol, an oral ferric iron preparation, is safe and effective in the treatment of iron deficiency anaemia (IDA) in subjects with inflammatory bowel disease (IBD).

Study Start Date: Sept. 01, 2021

Study Type: INTERVENTIONAL

Condition: Iron Deficiency Anaemia

Intervention: DRUG: Ferric Maltol

30 mg capsules to be taken orally twice a day for 12 weeks

DRUG: Placebo Oral Capsule

Matching placebo capsules for Ferric Mal...